Immtech has alliances with a group of talented and dedicated scientists who have spent their careers in pursuit of cures for infectious diseases.
Immtech Pharmaceuticals has an alliance with a consortium of universities and research
institute laboratories. This gives us access to accomplished scientists and development
teams whose members contribute to the discovery and development of compounds in our
medicinal chemistry library.
Two of our most widely published and respected lead scientists, Dr. Richard Tidwell and
Dr. David Boykin, have attracted a cadre of other renowned scientists to the consortium.
Together, they offer a depth of research knowledge and capabilities rivaled only by large,
multifaceted pharmaceutical companies.
Our scientists include:
Richard R. Tidwell, PhD
Head of Research
Director of the Research Consortium,
Chairman of the Scientific Advisory Board
David W. Boykin, PhD
Regents’ Professor Emeritus of Chemistry,
Georgia State University
Byron L. Blagburn, PhD
Department of Pathobiology
Christine C. Dykstra, PhD
Auburn University, College of Veterinary Medicine
Scott M. Franzblau, PhD
University of Illinois at Chicago
James E. Hall, PhD
UNC-CH School of Medicine
Dr. Hall received his B.S. and M.S. degrees from Louisiana State
University and his PhD degree in Biology from
Texas A&M University
and did his postdoctoral studies at the Center for Biological NMR in
the Chemistry Department at Texas A&M. Dr. Hall holds appointments
as Associate Professor in the Division of Drug Development and
in the School of Pharmacy and Pathology and Laboratory
Medicine in the School of Medicine at the University of North Carolina
at Chapel Hill. Dr. Hall has extensive experience using high-performance
liquid chromatography (HPLC) and other chromatographic procedures
combined with mass spectrometry (MS) and 13C nuclear magnetic
resonance spectroscopy (NMR).
© 2008 Immtech. All Rights Reserved